Comstock Announces Strategic Partnership with EFT Comstock has recently revealed a significant strategic partnership between its subsidiary, Comstock IP Holdings …
Read More »New catheter by Biosense Webster maps complex arrhythmias.
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, has introduced the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System in the United States. The OPTRELL™ Mapping Catheter is a high-density diagnostic catheter designed for mapping complex cardiac arrhythmias. It utilizes a fixed array formation with small electrodes …
Read More »